Get an early preview of the new iBridge Network

Access new technology search features and an extended innovation database with new transformative technologies
fed into the platform by our member Academic Institutions, Research Labs, SMEs, Startups


Munc18-1 and -2 double knockdown PC12 cells

University Health Network - Technology Development and Commercialization
posted on 03/12/2012

Available for licensing: Munc 18-1 and Munc 18-2 double knockdown PC12 cells.

Innovation Details

Detailed Description

"Munc18-1 binds to syntaxin-1A via two distinct sites referred to as the ‘closed’ conformation and Nterminus binding. The latter has been shown to stimulate SNARE-mediated exocytosis, whereas the former is believed to be inhibitory or dispensable. To precisely define the contributions of each binding mode, we have engineered Munc18-1/-2 double knockdown neurosecretory cells and show that not only syntaxin-1A and -1B but also syntaxin-2 and -3 were significantly reduced as a result of Munc18-1 and - 2 knockdown."

File Number: MD-PC12 

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact Yuan Lew at University Health Network - Technology Development and Commercialization for more information.

Request more info via email request more info

Case Manager:

Yuan Lew Yuan Lew

Innovations (37)

Download Technology Brief (PDF)

Followed By

Follow this innovation

No one is following this innovation.

Related Tags

Find more innovations

February 11, 2009

13,715 members 17,882 innovations 176 organizations


Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...